Drugs · Brain health technique
Valacyclovir
Evidence grade: Experimental
An oral antiviral medication (Valtrex®, the prodrug of acyclovir) used for HSV-1 and HSV-2 infections; being studied as a potential therapy to reduce viral reactivation implicated in Alzheimer’s risk.
- Practice
- Drugs
- Principle
- Treatment
- Tactic
- Neuroprotective & Disease-modifying Therapies
- Health domains
- inflammation
- Evidence grade
- Experimental
- Strength of evidence
- Low
- Cost
- High
- Effort
- Low
- Time commitment
- Low
How to practice Valacyclovir
Approved for antiviral use (cold sores, shingles, genital herpes) but not dementia prevention. For typical antiviral indications: 500–1000 mg orally 1–2× daily as prescribed upon outbreaks. Consider speaking to a physician about suppression (daily) therapy to prevent subclinical outbreaks that could increase dementia risk - though note this is an experimental use case.
The evidence behind Valacyclovir
Observational data link chronic herpesvirus infection to increased Alzheimer’s risk. Small pilot trials show reduced viral activity and inflammatory markers with valacyclovir, but no consistent cognitive improvement. Mechanism: suppressing HSV replication may limit neuroinflammation and amyloid deposition, but causality is unconfirmed. Evidence preliminary and low-powered.
More Drugs techniques
Take control of your brain health
BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.